Lauterbach Sandra Leigh 4
4 · Protalix BioTherapeutics, Inc. · Filed Feb 9, 2010
Insider Transaction Report
Form 4
Lauterbach Sandra Leigh
VP, Sales & Commercial Affairs
Transactions
- Award
Stock Options (Right to Buy)
2010-02-07+160,000→ 160,000 totalExercise: $6.81Exp: 2020-02-07→ Common Stock (160,000 underlying)
Footnotes (1)
- [F1]The options vest over a four-year period. The first 25% of the options vest on the first anniversary of the grant date and the remaining 75% of the options vest in 12 equal tranches on a quarterly basis during the subsequent three- year period.